CHRONIC GRAFT VERSUS HOST DISEASE AND PRETRANSPLANT DISEASE STATUS PREDICT OUTCOMES IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION

被引:0
|
作者
Shah, M. [1 ]
Agha, M. [1 ]
Mapara, M. [1 ]
Lenhart, K. [1 ]
Raptis, A. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh Canc Inst, Pittsburgh, PA 15261 USA
关键词
D O I
10.1016/j.bbmt.2007.12.333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
323
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [1] Chronic graft versus host disease and pretransplant disease status predict outcomes in patients with hematologic malignancies undergoing reduced intensity allogeneic stem cell transplantation
    Shah, Megha A.
    Agha, Mounzer
    Mapara, Markus
    Lenhart, Kate
    Raptis, Anastasios
    BLOOD, 2007, 110 (11) : 353B - 354B
  • [2] Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies
    Mineishi, S
    Kanda, Y
    Saito, T
    Nakai, K
    Makimoto, A
    Kami, M
    Tanosaki, R
    Wakasugi, H
    Tobinai, K
    Takaue, Y
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 296 - 303
  • [3] PROGNOSTIC IMPACT OF CHRONIC GRAFT VERSUS HOST DISEASE IN PATIENTS WITH MYELOID NEOPLASMS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION-A SINGLE INSTITUTION SERIES
    Gijima, D.
    Hogan, W.
    Litzow, M.
    Hashmi, S.
    Gastineau, D.
    Patnaik, M.
    HAEMATOLOGICA, 2013, 98 : 380 - 380
  • [4] Lung Transplantation for Chronic Graft Versus Host Disease after Allogeneic Stem Cell Transplantation
    Holm, A. M.
    Riise, G. C.
    Hansson, L.
    Bjortuft, O.
    Brinch, L.
    Simonsen, S.
    Floisand, Y.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S58 - S59
  • [5] Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation
    Lopez Corral, Lucia
    Blazquez Goni, Cristina
    Perez Lopez, Estefania
    Martin Dominguez, Francisco Manuel
    Cabero Martinez, Almudena
    Rodriguez Torres, Nancy
    Cabrero Calvo, Monica
    Espigado, Ildefonso
    Martin Lopez, Ana Africa
    Parody, Rocio
    Baile Gonzalez, Monica
    Caballero, Teresa
    Cortes-Rodriguez, Maria
    Soria Saldise, Elena
    Avendano Pita, Alejandro
    Alcalde Mellado, Patricia
    Garcia Bacelar, Ana
    Rodriguez Arboli, Eduardo
    Lopez Parra, Miriam
    Francisco Falantes, Jose
    Navarro Bailon, Almudena
    Vazquez Lopez, Lourdes
    Escamilla Gomez, Virginia
    Martin, Fermin Sanchez-Guijo
    Perez-Simon, Jose A.
    BLOOD, 2023, 142
  • [6] Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation
    Sanchez-Petitto, Gabriela
    Goloubeva, Olga
    Childress, James
    Iqbal, Tahreem
    Masur, Jack
    An, Max
    Muhammad, Safwan
    Lawson, Justin
    Li, Grace
    Barr, Brian
    Emadi, Ashkan
    Duong, Vu H.
    Hardy, Nancy M.
    Rapoport, Aaron P.
    Baer, Maria R.
    Niyongere, Sandrine
    Yared, Jean A.
    ACTA HAEMATOLOGICA, 2024,
  • [7] A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
    Haverkos, Bradley M.
    Cortright, Katie
    Andritsos, Leslie A.
    Blum, William
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Goldenberg, David M.
    Wegener, William A.
    Devine, Steven M.
    Jaglowski, Samantha M.
    BLOOD, 2014, 124 (21)
  • [8] A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies
    Haverkos, Brad
    Cortright, Katie
    Andritsos, Leslie A.
    Blum, William
    Klisovic, Rebecca
    Vasu, Sumithira
    Goldenberg, David M.
    Wegener, William
    Devine, Steven M.
    Jaglowski, Samantha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S331 - S332
  • [9] Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation
    Busca, A
    Rendine, S
    Locatelli, F
    Sizzano, F
    Dall'Omo, AM
    Rossi, G
    Falda, M
    HEMATOLOGY, 2005, 10 (01) : 1 - 10
  • [10] Comparison of Outcomes with Two Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylactic Regimens after Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
    Khanal, Rashmi
    Sedov, Valeriy
    Gupta, Ridhi
    Burbridge, Mark Thomas
    Butcher, Colleen
    Capdevila, Kylie
    Edwards, Kathy Hogan
    Martin, Kristy
    Littleton, Amanda
    Kramer, Cindy
    Schneider, Molly
    Varela, Juan Carlos
    Williams, Elizabeth J.
    Stuart, Robert
    Chhabra, Saurabh
    Gentles, Carolyn Ann
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S330 - S331